Related Experiment Video
Updated: Apr 26, 2026
08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
6.8K
A novel assay system for macrophage-activating factor activity using a human U937 cell line
Mami Ishikawa1, Takahiro Inoue1, Toshio Inui2
1Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan.
Anticancer Research
|July 31, 2014
Summary
Researchers developed a new assay to measure macrophage phagocytic activity. This simple, rapid method effectively assesses group-specific component protein-derived macrophage-activating factor (GcMAF) activity for cancer immunotherapy research.
Area of Science:
- Immunology
- Cancer Research
- Cell Biology
Background:
- Macrophages are crucial for anti-tumor immunity.
- Group-specific component protein-derived macrophage-activating factor (GcMAF) immunotherapy shows promise in various cancers.
- Accurate assessment of macrophage activity is vital for research and clinical applications.
Purpose of the Study:
- To establish a novel, reliable assay for evaluating macrophage phagocytic activity.
- To enable sensitive detection of macrophage-activating factor (MAF) activity.
Main Methods:
- U937 macrophages were differentiated using 12-O-tetradecanoyl-13-phorbolacetate (TPA).
- Phagocytic activity was quantified by measuring the ratio of internalized beads.
- MAF activity was assessed 30 minutes post-addition, determining the activation ratio.
Main Results:
- A novel assay for evaluating phagocytic activities in differentiated U937 macrophages was successfully established.
- The assay demonstrated sensitivity in detecting MAF activity.
Conclusions:
- The developed protocol is simple, rapid, and sensitive for GcMAF.
- This assay is valuable for basic research on macrophage activation mechanisms.
- The protocol can be applied to clinical studies for assessing GcMAF efficacy before use.
